|
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation |
Burr JM, Botello-Pinzon P, Takwoingi Y, Hernandez R, Vazquez-Montes M, Elders A, Asaoka R, Banister K, van der Schoot J, Fraser C, King A, Lemij H, Sanders R, Vernon S, Tuulonen A, Kotecha A, Glasziou P, Garway-Heath D, Crabb D, Vale L, Azuara-Blanco A, Perera R, Ryan M, Deeks J, Cook JK |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Burr JM, Botello-Pinzon P, Takwoingi Y, Hernandez R, Vazquez-Montes M, Elders A, Asaoka R, Banister K, van der Schoot J, Fraser C, King A, Lemij H, Sanders R, Vernon S, Tuulonen A, Kotecha A, Glasziou P, Garway-Heath D, Crabb D, Vale L, Azuara-Blanco A, Perera R, Ryan M, Deeks J, Cook JK. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation. Health Technology Assessment 2012; 16(29): 1-272 Indexing Status Subject indexing assigned by NLM MeSH Administration, Ophthalmic; Age Factors; Antihypertensive Agents /administration & Cohort Studies; Cost-Benefit Analysis; Glaucoma, Open-Angle /prevention & Humans; Intraocular Pressure; Mass Screening; Models, Theoretical; Ocular Hypertension /drug therapy /economics /epidemiology; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Assessment; control; dosage /economics /therapeutic use AccessionNumber 22012023590 Date bibliographic record published 29/11/2012 |
|
|
|